- 专利标题: USE OF LACTULOSE IN THE TREATMENT OF AUTISM
-
申请号: US16422079申请日: 2019-05-24
-
公开(公告)号: US20190275066A1公开(公告)日: 2019-09-12
- 发明人: Joan M. Fallon , Richard Feltenstein
- 申请人: Curemark, LLC
- 主分类号: A61K31/7016
- IPC分类号: A61K31/7016 ; A61K31/047 ; A61K31/045 ; A61K31/7012
摘要:
A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity.
公开/授权文献
- US11033563B2 Use of lactulose in the treatment of autism 公开/授权日:2021-06-15
信息查询